🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this i-SABR (immunotherapy + Stereotactic Ablative Body Radiation) trial...
Status
Completed
Location
University of Texas Southwestern Medical Center
Start Date
2013-10-02
Trial ID
NCT01896271
Treatments Being Tested
The purpose of this study is to evaluate the safety of the experimental dru...
Status
Completed
Location
Multiple Locations
Start Date
2002-12
Trial ID
NCT00059462
Treatments Being Tested
This is a pilot clinical trial investigating the addition of haploidentical...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2014-10-10
Trial ID
NCT02130869
-Purpose: Phase I: To test the methods, data collection and analysis in a s...
Status
Completed
Location
Duke University Hospital
Start Date
2015-02-16
Trial ID
NCT02150369
This is a single center Phase I clinical trial of FT516 administered intrap...
Status
Completed
Location
University of Minnesota, Masonic Cancer Center
Start Date
2021-04-02
Trial ID
NCT04630769
Treatments Being Tested
This experiment will test the safety and effectiveness of a treatment for m...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
1999-08
Trial ID
NCT00001832
This phase II trial studies how well high-dose aldesleukin and ipilimumab w...
Status
Terminated
Location
Loyola University Medical Center
Start Date
2014-11-26
Trial ID
NCT02203604
Treatments Being Tested
Background: * The National Cancer Institute (NCI) Surgery Branch has devel...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2013-12-12
Trial ID
NCT01993719
Adoptive T cell therapy (ACT) with tumor infiltrating lymphocytes (TIL) has...
Status
Completed
Location
Center for Cancer Immune Therapy Dept. of Hematology/oncology
Start Date
2016-12
Trial ID
NCT02926053
This is a Phase 1/2, study evaluating IOV-2001 (Adoptive Cell Therapy) comp...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2020-02-19
Trial ID
NCT04155710
Treatments Being Tested